{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~33 mi. (East Stroudsburg, Pennsylvania, +825 more cities)
facility
Pocono Medical Center
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
~33 mi. (East Stroudsburg, Pennsylvania, +327 more cities)
facility
Pocono Medical Center
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~33 mi. (East Stroudsburg, Pennsylvania, +469 more cities)
facility
Pocono Medical Center
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
city
~33 mi. (Sparta, New Jersey, +224 more cities)
facility
Sparta Cancer Treatment Center
condition
Hypopharyngeal Carcinoma, +3 more conditions
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +3 more types
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
city
~33 mi. (East Stroudsburg, Pennsylvania, +413 more cities)
facility
Pocono Medical Center
drug
ipilimumab, +2 more drugs
drug type
immunotherapy, +1 more type